PRME vs TFX · rev $4.6M vs P/E 2083, rev $1.12B
Prime Medicine, Inc. Common Stock (PRME) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
PRME currently screens at market cap $570.8M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the PRME and TFX stock pages for the full models.
Not investment advice.